Infectious ocular complications have been reported followsequently, these patients were followed up longitudinally for response to treatment and outcome. Records of patients with ing solid organ and bone marrow transplantation [1 -4] . The ocular infections were reviewed for demographics, indication optic fundus may be affected by an opportunistic infection that for OLT, immunosuppressive treatment, episodes of rejection, is an independent focus or part of a systemic infection. In postoperative complications, time from OLT to ocular infecaddition, noninfectious ocular complications, which are usually tion, findings of ocular examination, presence of systemic disattributed to the direct toxic effects of immunosuppressants, ease, therapy, surgical procedures, and outcome of ocular infecmay occur [2 -6] . Clinical manifestations of ocular infections tions. in transplant patients are often atypical; mixed infections or Immunosuppressive therapy with cyclosporine, azathioprine, noninfectious complications may coexist [7, 8] . Timely diagnoand steroids was given until May 1994 as follows: sis and administration of specific treatment are essential for cyclosporine -5 mg/kg orally twice a day (dose adjusted until preservation of vision. We report the types and frequency of whole blood trough level was 350 -400 ng/mL); azathioprineocular infections that occurred in liver transplant patients at 1 -2 mg/kg orally once a day (dose adjusted based on WBC Mount Sinai Hospital (New York) during a 6-year period. The count); and steroids -intravenous hydrocortisone (1,000 mg clinical presentations and diagnostic and therapeutic strategies intraoperatively), intravenous methylprednisolone (200 mg, are reviewed.
160 mg, 120 mg, 80 mg, and 40 mg [in four divided doses] on postoperative days 1, 2, 3, 4, and 5, respectively), and Patients and Methods prednisone (20 mg orally per day). Over 1 year, the prednisone dosage was reduced to 5 -10 mg orally per day. All patients underwent orthotopic liver transplantation From 1991 to May 1994, 138 patients received tacrolimus (OLT) at The Mount Sinai Medical Center. Patients with ocular (0.05 mg/kg orally twice a day; dose adjusted until whole blood symptoms were referred for ophthalmology consultation. Subtrough level was 10 -20 ng/mL) in randomized trials and as rescue therapy. Since June 1994, tacrolimus has been used as standard immunosuppressive therapy except for patients with NOTE. AmB Å amphotericin B; Aza Å azathioprine; CMV Å cytomegalovirus; Cysp Å cyclosporine; Czid Å ceftazidime; D Å donor; Em Å erythromycin; Flu Å fluconazole; NA Å not available; OLT Å orthotopic liver transplantation; Pip Å piperacillin; Prd Å prednisone; R Å recipient; Tm Å tobramycin; TMP-SMZ Å trimethoprim-sulfamethoxazole; Vm Å vancomycin; / Å positive; 0 Å negative. 1 year) as prophylaxis for cytomegalovirus (CMV) infection.
one patient with C. albicans endophthalmitis and in one with CMV retinitis. In addition, CMV-negative recipients were treated with intrave-
The diagnosis of fungal infection was made by gram staining nous immune globulin (500 mg/kg weekly for four doses and of vitreous fluid in two cases; C. albicans was detected in one then every 14 days for an additional four doses). All patients case, and A. fumigatus was detected in the other. Patient 1 was received trimethoprim-sulfamethoxazole (80 mg/400 mg daily treated initially for toxoplasma chorioretinitis with sulfamethfor 1 year after OLT) as prophylaxis for Pneumocystis carinii oxazole, pyrimethamine, and folinic acid. Follow-up examinainfection. All patients received clotrimazole troches (five times tion 2 weeks later showed dense vitreitis with vitreous strands a day for 1 year after OLT). In addition, female patients re-(figure 1). The patient underwent pars plana vitrectomy. Culture ceived nystatin vaginal tablets once daily during hospitalizaof the vitreous yielded C. albicans. Patient 2 was initially tion.
asymptomatic when funduscopic examination was done. However, she later developed blurred vision while receiving treatment with amphotericin B, and results of follow-up funResults duscopic examination were consistent with candidal endophFrom 3 September 1988 through 11 November 1994, 684 thalmitis. Patient 3 was intubated and unresponsive when opacipatients underwent OLT. Ocular infections occurred in nine fication of the cornea developed. The diagnosis of A. fumigatus (1.3%) of these patients. The demographics and baseline cliniendophthalmitis was made by staining of vitreous fluid obcal characteristics of the patients with ocular infections were tained by vitreal aspiration; disseminated aspergillosis was similar to those of the whole group of patients who underwent noted at autopsy. OLT. There were four females and five males; the mean age
The diagnosis of viral infection was made on the basis of of the nine patients was 47.2 years (range, 5 -57 years), comthe funduscopic appearance. Three patients with CMV retinitis pared with 45 years for all transplant recipients. The demohad serological evidence of acute CMV infection (i.e., the presgraphics and clinical characteristics of the nine patients are ence of IgM antibodies). Patient 7 had CMV retinitis and conshown in table 1. Six patients were treated for rejection. comitant CMV pneumonia. Three patients developed endophthalmitis due to fungi
The treatment and outcome of ocular infections are shown (Candida albicans, two; Aspergillus fumigatus, one). CMV in table 3. Systemic amphotericin B therapy (dose range, 1 -2 retinitis occurred in four patients; varicella-zoster virus g) was used to treat fungal endophthalmitis. Patient 1 required panophthalmitis and herpes simplex virus (HSV) keratitis treatment with vitrectomy and intravitreal amphotericin B in were found in one patient each. Permanent total loss of vision occurred in three patients. A ciclovir treatment, and her condition progressed to loss of vision. Another patient with CMV retinitis (case 9) had serologipatient with CMV retinitis (case 8) presented with serological evidence of CMV infection (presence of IgM antibodies) and cal evidence of acute CMV infection; this patient responded to intravenous ganciclovir therapy but had subsequent retinal papilledema (figure 2); this patient did not respond to ganvein occlusion. One patient with varicella-zoster virus panophthalmitis (case 4) developed a blind, painful eye that required enucleation. Five patients had improvement in visual acuity following treatment; one patient died of disseminated aspergillosis 33 days after OLT.
Discussion
The incidence of ocular infections following kidney, heart, and bone marrow transplantations has been previously reported to vary between 2% and 5% [2 -4]. In our study, the incidence of ocular infections in orthotopic liver transplant patients was 1.3%. Fungal infections appeared earlier (mean, 42 days) than viral infections (mean, 128 days). This finding is in agreement with prior reports of the timing of ocular infections in the posttransplantation period [2, 3] . Life-threatening bacterial and indirect effects of underlying disease, major surgery, risk of mosis or candidal infection or with retinal vein occlusion when there are extensive hemorrhages [13] . In one report [14] , the wound and nosocomial infections, and large doses of immunosuppressants. The early postoperative period also covers the use of tacrolimus as immunosuppressive therapy was associated with an increased incidence of CMV retinitis. incubation period of herpesviruses, like CMV, HSV, and Epstein-Barr virus, that may be transmitted during transplanta-
The natural history of CMV retinitis may be different in immunocompromised patients with AIDS than in those without tion or reactivated because of immunosuppression.
In our study, CMV retinitis was the most common ocular AIDS. In patients with AIDS, if left untreated, CMV retinitis causes partial or complete visual loss [10] . Intravenous infuinfection. CMV retinitis was first described in immunocompromised hosts in 1959 [9] . CMV retinitis is the most common sions of ganciclovir or foscarnet are required for maintenance therapy [15] . Immunocompromised patients without AIDS may opportunistic infection in patients with AIDS, occurring in up be asymptomatic at the time of diagnosis in up to 50% of the to 40% of patients [10, 11] . In transplant patients, the appearcases [12] . Before the availability of specific antiviral treatance of CMV retinitis is typical, with characteristic vessel ment, a number of patients' conditions improved as requiresheathing, edematous and hemorrhagic lesions with actively ments for maintenance immunosuppressive therapy diminished extending borders, and a pallid necrotic center [12] . Larger in the late posttransplantation period [12] . Since the availability lesions can be confused with retinitis associated with toxoplasof specific treatment, resolution has been reported following induction therapy alone [16 -18] . In our study, the conditions of two of four patients with CMV retinitis improved with induction therapy, and disease did not recur during follow-up; none of these patients received maintenance therapy. However, one patient died of a nonrelated cause at 7 months of follow-up. Currently, the exact incidence of CMV retinitis in liver transplant patients is unknown. Since relapse or retinal detachment may occur [19] , we recommend careful follow-up of patients whose disease has resolved.
In our study, two of four cases of CMV retinitis developed in CMV-seronegative recipients of a CMV-seropositive liver. Patient 7 had concomitant CMV pneumonia; because of persistent shortness of breath, he was treated with a prolonged course of ganciclovir therapy and subsequent foscarnet therapy. Preexisting diabetic retinopathy in this patient obscured the diagnosis of CMV retinitis. The use of immunosuppressive therapy with OKT-3 monoclonal antibodies for hepatitis C may have con- [27, 33 -41] . Aggressive vitreoretinal diagnostic procedures are recommended for selected patients, since the vitreous humor sive therapy with tacrolimus and presented with optic disk edema, which has been previously reported as a manifestation is the intraocular site with the highest yield of bacterial and fungal pathogens. Smears should be treated with gram, Giemsa, of CMV retinitis in transplant patients [12] . Cyclosporine therapy for bone marrow transplant recipients has been associated and periodic acid -Schiff stains and examined. Fluorochrome stains are sensitive for detecting mycobacteria or fungi. Conwith optic disk edema [20] . Tacrolimus therapy is not known to be associated with optic disk edema. However, case 8 may centrating the fluid obtained by vitrectomy by means of centrifuging or passing through a Millipore filter (Millipore, Marlborbe the first reported case of tacrolimus toxicity. Patient 8 did not respond to ganciclovir therapy and eventually had complete ough, MA) may increase the yield. Cytological examination of the vitreous specimen is important since ocular malignancy is loss of vision in the right eye.
Candidal endophthalmitis usually presents with distinctive a potential complication of the immunosuppressed state [2, 42] . Standard prophylactic regimens for liver transplant patients signs demonstrated by funduscopic examination [21] . In case 1, the funduscopic appearance was atypical, and there was offer some protection against pathogens that may cause ocular infections. Trimethoprim-sulfamethoxazole prophylaxis for no clinical or laboratory evidence of disseminated candidal infection. This patient probably had transient candidemia dur-P. carinii infection is also effective against infection due to T. gondii, L. monocytogenes, and Nocardia species. Acyclovir ing hospitalization for OLT, with subsequent seeding of the eye. The appearance of ''stranding,'' which has been reported therapy has been shown to reduce the incidence of CMV disease in orthotopic liver transplant patients [43] . However, its by other investigators [22] , led to initial therapy for toxoplasmosis.
efficacy in preventing CMV retinitis in these patients has not been studied. This case underlines the need for an early aggressive workup with vitreal aspiration when the diagnosis is unclear. In case Current approaches to the management of ocular infections include intravitreal antibiotic therapy and novel antiviral and 2, candidal endophthalmitis was diagnosed in the context of hospital-acquired candidemia. Retinal involvement with candiantifungal therapy in combination with mechanical vitrectomy. Amphotericin B has been the standard treatment of candidal demia may occur in 37% of patients [23, 24] . Ophthalmologic examination is recommended for asymptomatic patients with endophthalmitis; a cure rate of 92% has been associated with this therapy [44] . Fluconazole has minimal toxic effects, is candidemia and risk factors [25] .
Disseminated fatal aspergillosis developed in a gravely ill well absorbed orally, and achieves high concentrations in the chambers of the eye [45, 46] . A limited number of studies have patient (case 3) while empirical treatment with fluconazole was being administered. Panophthalmitis is usually a manifestation reported cure rates of up to 94% among patients with candidal endophthalmitis who were treated with fluconazole [47] . Lipoof generalized aspergillosis [26] . A recent report [27] described seven cases of aspergillus endophthalmitis associated with somal amphotericin B therapy may be of value, but studies are needed to prove its efficacy. Oral ganciclovir, intravitreal OLT; the cases were diagnosed at autopsy (all with disseminated infection). The use of low doses of amphotericin B has ganciclovir, foscarnet, and cidofovir are currently used in the management of patients with AIDS and CMV retinitis [15] . been shown to reduce the incidence and mortality rate associated with invasive aspergillosis in bone marrow transplant paSome of these treatment modalities may prove useful for the transplant population. tients [28] . In addition, itraconazole has been used successfully as therapy for patients with chronic granulomatous disease [29] .
In conclusion, infection should always be considered in liver transplant patients with ocular symptoms. The funduscopic apHowever, invasive aspergillosis has occurred in liver transplant recipients receiving low doses of amphotericin B [30] and bone pearance in orthotopic liver transplant patients may be atypical, and findings may be superimposed on noninfectious preexisting marrow transplant patients receiving fluconazole therapy [31] .
Patient 5 developed HSV keratitis and CMV colitis shortly pathology. A high index of suspicion and aggressive intravitreal procedures may be needed to establish a diagnosis. Treatment after a rejection episode. In addition, this patient had esophageal candidiasis and gastrointestinal Kaposi's sarcoma. The should be directed against the specific pathogen, with reduced doses of immunosuppressants whenever possible. Selected paadditional immunosuppressants used for treatment of rejection may have contributed to the reactivation of HSV and CMV tients may benefit from screening and planned eye examinations following transplantation. diseases. Herpetic lesions in the immunocompromised host tend to persist or recur with topical therapy in up to 33% of cases within 24 months unless the dose of immunosuppressive medications is reduced [32] . Our patient responded to oral References acyclovir therapy without recurrence. 
